









Markets
/
Stocks
/
nasdaq-cor
/

Cencora Inc

COR

291.630USD

-10.890-3.60%

Close 09/15, 16:00（ET）Quotes delayed by 15 min

56.54BMarket Cap

29.80P/E TTM



Cencora Inc

291.630

-10.890-3.60%

Overview Company Financials Analysis

TradingKey Stock Score

Overall Financial Health

Valuation Dimensions

Earnings Forecast

Price Momentum

Institutional Confidence

Risk Assessment

Peer Comparison

TradingKey Stock Score

Currency: USD Updated：2025-09-12

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered undervalued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking

2 / 207

Overall Ranking

45 / 4724

Industry

Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score

Previous score

Analyst Rating

Based on 18 analysts

Buy

Current Rating

331.461

Target Price

+9.57%

Upside Space

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks

Cencora, Inc. is a global pharmaceutical sourcing and distribution services company. The Company is focused on improving the lives of people and animals around the world. It is engaged in the delivery of pharmaceuticals, healthcare products, and solutions. The Company operates through two segments: U.S. Healthcare Solutions and International Healthcare Solutions. The U.S. Healthcare Solutions segment distributes a comprehensive offering of brand-name, specialty brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a variety of healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, long-term care and alternate site pharmacies, and other customers. The International Healthcare Solutions segment consists of businesses that focus on international pharmaceutical wholesale and related service operations and global commercialization services.

Industry Leader

The company's revenue leads the industry, with the latest annual revenue totaling USD 293.96B.

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 23.21% year-on-year.

High Dividend

The company is a high dividend payer, with the latest dividend payout ratio of 27.58%.

Fairly Valued

The company’s latest PE is 30.81, at a medium 3-year percentile range.

Institutional Selling

The latest institutional holdings are 191.45M shares, decreasing 0.10% quarter-over-quarter.

Held by The Vanguard

Star Investor The Vanguard holds 22.40M shares of this stock.

Financial Health

Currency: USD Updated：2025-09-12

The company's current financial score is 9.02, which is higher than the Healthcare Equipment & Supplies industry's average of 7.15. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 75.45B, representing a year-over-year increase of 10.29%, while its net profit experienced a year-over-year increase of 70.61%.

Score

Industry at a Glance

Previous score

9.02

Change



Financials

7.37

Key Metrics

Cash and cash equivalents

Total assets

Total liabilities

Free cash flow

No Data



Quality of Earnings

10.00

Key Metrics

Total revenue

Operating profit

Total assets

SG&A

No Data



Operational Efficiency

8.08

Key Metrics

Cash flow from operating activities

Income after tax

No Data



Growth Potential

10.00

Key Metrics

Cash flow from operating activities

Total revenue

No Data



Shareholder Returns

9.64

Key Metrics

Free cash flow

No Data

Company Valuation

Currency: USD Updated：2025-09-12

The company’s current valuation score is 1.80, which is lower than the Healthcare Equipment & Supplies industry's average of 2.15. Its current P/E ratio is 29.59, which is 12.15% below the recent high of 33.19 and -1.62% above the recent low of 30.07.

Score

Industry at a Glance

Previous score

1.80

Change

Valuation Dimensions

P/E

P/B

P/S

P/CF

Industry Ranking 2/207

No Data

Earnings Forecast

Currency: USD Updated：2025-09-12

The company’s current earnings forecast score is 7.78, which is higher than the Healthcare Equipment & Supplies industry's average of 7.66. The average price target for Cencora Inc is 337.50, with a high of 355.00 and a low of 257.45.

Score

Industry at a Glance

Previous score

7.89

Change

Support & Resistance

No Data

Analyst Rating

Based on 18 analysts

Buy

Current Rating

331.461

Target Price

+9.57%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

118

Total

Median

Average

Company name

Ratings

Analysts

Cencora Inc

COR

Medtronic PLC

MDT

Stryker Corp

SYK

Abbott Laboratories

ABT

Zimmer Biomet Holdings Inc

ZBH

Dexcom Inc

DXCM

...

Financial Forecasting

EPS

Revenue

Net Profit

EBIT

No Data

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated：2025-09-12

The company’s current price momentum score is 7.58, which is higher than the Healthcare Equipment & Supplies industry's average of 7.47. Sideways: Currently, the stock price is trading between the resistance level at 306.75 and the support level at 273.90, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score

7.35

Change

1.82

Support & Resistance

No Data

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators

Sell(1)

Neutral(2)

Buy(3)

Indicators

Value

Direction

MACD(12,26,9)

2.009

Buy

RSI(14)

60.434

Neutral

STOCH(KDJ)(9,3,3)

76.960

Neutral

ATR(14)

4.938

Low Volatility

CCI(14)

182.368

Buy

Williams %R

24.679

Buy

TRIX(12,20)

0.082

Sell

StochRSI(14)

93.893

Overbought

Moving Average

Sell(5)

Neutral(0)

Buy(1)

Indicators

Value

Direction

MA5

299.634

Sell

MA10

296.497

Sell

MA20

295.041

Sell

MA50

293.364

Sell

MA100

291.848

Sell

MA200

271.670

Buy

Institutional Confidence

Currency: USD Updated：2025-09-12

The company’s current institutional recognition score is 10.00, which is higher than the Healthcare Equipment & Supplies industry's average of 7.19. The latest institutional shareholding proportion is 98.75%, representing a quarter-over-quarter decrease of 0.55%. The largest institutional shareholder is The Vanguard, holding a total of 22.40M shares, representing 11.55% of shares outstanding, with 5.19% increase in holdings.

Score

Industry at a Glance

Previous score

10.00

Change

Institutional Shareholding

No Data

Shareholder Activity

Name

Shares Held

Chg %

The Vanguard Group, Inc.

Star Investors

21.28M

+0.24%

BlackRock Institutional Trust Company, N.A.

11.01M

+2.17%

State Street Global Advisors (US)

8.41M

+4.76%

Walgreens Boots Alliance Inc

9.62M

-7.37%

T. Rowe Price Associates, Inc.

Star Investors

9.33M

+8.41%

Geode Capital Management, L.L.C.

4.50M

+4.10%

Boston Partners

5.41M

+8.07%

Wellington Management Company, LLP

5.42M

+7.18%

Fidelity Management & Research Company LLC

2.03M

+19.67%

Managed Account Advisors LLC

2.65M

+10.10%

Risk Assessment

Currency: USD Updated：2025-09-12

The company's beta value is 0.62. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.